6.740GBp+3.69%Mkt Cap: 463.93M $P/E: —1d ago
Allergy Therapeutics plc, a commercial biotechnology company, focuses on the diagnosis and treatment of allergic disorders in Germany, Austria, United Kingdom, Netherlands, Switzerland, Italy, Spain, and internationally.…
Industry Peers
Drug Manufacturers - Specialty & GenericIndicators:|
Key Statistics
Company
Market Cap463.93M $
Enterprise Value452.02M $
Revenue (TTM)62.28M $
Gross Profit31.85M $
Net Income (TTM)-43.62M $
Revenue/Share0.0120 USD
Last Price6.740 GBp
Fiscal Year EndJun 2025
MR QuarterDec 2025
Employees584
CountryGB
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-9.03
PEG—
EV/EBITDA-13.16
EV/Revenue7.26
P/S7.18
P/B65.00
EPS (TTM)-0.01
EPS (Forward)-0.01
52W Range
0.000056% of range12.10
52W High12.10 GBp
52W Low0.0000 GBp
Profitability
Gross Margin53.23%
Oper. Margin-31.35%
EBITDA Margin-55.16%
Profit Margin-72.91%
ROE142.35%
ROA-59.42%
Growth
Revenue Growth6.60%
Earnings Growth—
Cash Flow & Leverage
Operating CF-30.55M $
CapEx (TTM)3.72M $
FCF Margin-42.18%
FCF Yield-5.66%
Net Debt18.12M $
Net Debt/EBITDA-0.53
Balance Sheet
Debt/Equity-2.13
Current Ratio1.13
Quick Ratio0.70
Book Value/Sh0.0010 GBp
Cash/Share0.0020 GBp
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 GBp
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)13.00 GBp
Upside (mean)+92.9%
Target Range13.00 GBp – 13.00 GBp
# Analysts1
Ownership
Shares Out.6.33B
Float701.66M
Insiders88.49%
Institutions0.01%
Technical
SMA 508.199 (-17.8%)
SMA 2009.855 (-31.6%)
Beta0.87
S&P 52W Chg20.25%
Avg Vol (30d)197.83K
Avg Vol (10d)189.97K
Technical Indicators
RSI (14)41.8
MACD-0.4370
MACD Signal-0.5239
MACD Hist.+0.0869
BB Upper7.647 GBp
BB Middle6.917 GBp
BB Lower6.187 GBp
BB Width21.09%
ATR (14)0.9786 GBp
Vol Ratio (20d)0.36x